Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis

Arthritis Research and Therapy

Volumn 6, Issue 1, 2003, Pages

  Chuang, I Chuan ^a   Jhao, Chien Ming ^b   Yang, Chih Hsun ^c   Chang, Hsien Chang ^a   Wang, Chien Wen ^a   Lu, Cheng Yuan ^c   Chang, Yao Jen ^c   Lin, Sheng Han ^c   Huang, Pao Lin ^d   Yang, Lin Cheng ^d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

electroporation; gene delivery; pro opiomelanocortin; RT PCR; skeletal muscle

Indexed keywords

EID: 5044224312     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1014     Document Type: Article

References (27)

1. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, Smith LC: Gene therapy for the treatment of hemophilia b using pinc-formulated plasmid delivered to muscle with electroporation. Mol Ther. 2001, 3: 574-583. 10.1006/mthe.2001.0295. DOI: 10.1006/mthe.2001.0295
2. Haecker SE, Stedman HH, Balice-Gordon RJ: In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther. 1996, 7: 1907-1914. DOI: 10.1089/hum.1996.7.15-1907
3. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 1998, 5: 40-49. 10.1038/sj.gt.3300548. DOI: 10.1038/sj.gt.3300548
4. Rizzuto G, Cappelletti M, Mennuni C, Wiznerowicz M, DeMartis A, Maione D, Ciliberto G, La Monica N, Fattori E: Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther. 2000, 11: 1891-1900. 10.1089/10430340050129503. DOI: 10.1089/10430340050129503
5. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, Bianchini G, Stillo F, Capogrossi MC, Madeddu P: Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation. 2001, 103: 125-132. DOI: 10.1161/01.CIR.103.1.125
6. Lucas ML, Heller R: Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther. 2001, 3: 47-53. 10.1006/mthe.2000.0233. DOI: 10.1006/mthe.2000.0233
7. Schafer M, Carter L, Stein C: Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA. 1994, 91: 4219-4223. DOI: 10.1073/pnas.91.10.4219
8. Lu CY, Chou AK, Wu CL, Yang CH, Chen JT, Wu PC, Lin SH, Muhammad R, Yang LC: Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats. Gene Ther. 2002, 9: 1008-1014. 10.1038/sj.gt.3301774. DOI: 10.1038/sj.gt.3301774
9. Feero WG, Rosenblatt JD, Huard J, Watkins SC, Epperly M, Clemens PR, Kochanek S, Glorioso JC, Partridge TA, Hoffman EP: Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther. 1997, 8: 371-380. DOI: 10.1089/hum.1997.8.4-371
10. Evans CH, Ghivizzani SC, Oligino TA, Robbins PD: Future of adenoviruses in the gene therapy of arthritis. Arthritis Res. 2001, 3: 142-146. 10.1186/ar291. DOI: 10.1186/ar291
11. Huard J, Krisky D, Oligino T, Marconi P, Day CS, Watkins SC, Glorioso JC: Gene transfer to muscle using herpes simplex virus-based vectors. Neuromuscul Disord. 1997, 7: 299-313. 10.1016/S0960-8966(97)00054-0. DOI: 10.1016/S0960-8966(97)00054-0
12. Ozawa CR, Springer ML, Blau HM: A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Annu Rev Pharmacol Toxicol. 2000, 40: 295-317. 10.1146/annurev.pharmtox.40.1.295. DOI: 10.1146/annurev.pharmtox.40.1.295
13. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel JL: Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA. 1992, 89: 2581-2584. DOI: 10.1073/pnas.89.7.2581
14. Vincent N, Ragot T, Gilgenkrantz H: Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a mini-dystrophin gene. Nat Genet. 1993, 5: 130-134. 10.1038/ng1093-130. DOI: 10.1038/ng1093-130
15. Clemens PR, Kochanek S, Sunada Y: In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 1996, 3: 965-972.
16. Kumar-Singh R, Chamberlain JS: Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet. 1996, 5: 913-921. 10.1093/hmg/5.7.913. DOI: 10.1093/hmg/5.7.913
17. Chang DC, Gao PQ, Maxwell BL: High efficiency gene transfection by electroporation using a radio-frequency electric field. Biochim Biophys Acta. 1991, 1092: 153-160. 10.1016/0167-4889(91)90149-R. DOI: 10.1016/0167-4889(91)90149-R
18. Liu F, Huang L: A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther. 2002, 5: 323-328. 10.1006/mthe.2002.0540. DOI: 10.1006/mthe.2002.0540
19. Lin CR, Yang LC, Lee TH, Lee CT, Huang HT, Sun WZ, Cheng JT: Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther. 2002, 9: 1247-1253. 10.1038/sj.gt.3301790. DOI: 10.1038/sj.gt.3301790
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159. 10.1006/abio.1987.9999. DOI: 10.1016/0003-2697(87)90021-2
21. Johnson PA, Wong MJ, Friedman T: Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shut-off function. J Virol. 1994, 68: 6347-6362.
22. Marconi P, Krisky D, Oligino T: Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci USA. 1996, 93: 11319-11320. 10.1073/pnas.93.21.11319. DOI: 10.1073/pnas.93.21.11319
23. Acsadi G, Lochmuller H, Jani A: Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther. 1996, 7: 129-140. DOI: 10.1089/hum.1996.7.2-129
24. Gilchrist SC, Ontell MP, Kochanek S, Clemens PR: Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector. Mol Ther. 2002, 6: 359-368. 10.1006/mthe.2002.0675. DOI: 10.1006/mthe.2002.0675
25. Axelrod D, Preston S: Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum. 1988, 31: 803-805. DOI: 10.1002/art.1780310618
26. Panerai AE, Manfredi B, Granucci F, Sacerdote P: The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/ autocrine effects of opioid. J Neuroimmunol. 1995, 58: 71-76. 10.1016/0165-5728(94)00189-U. DOI: 10.1016/0165-5728(94)00189-U
27. Panerai AE, Radulovic J, Monastra G, Manfredi B, Locatelli L, Sacerdote P: Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease. J Neuroimmunol. 1994, 51: 169-176. 10.1016/0165-5728(94)90078-7. DOI: 10.1016/0165-5728(94)90078-7